Badger Meter, Inc. provides flow-measurement, control, and communications solutions focused mainly on water management. I follow the company because it bridges essential utility infrastructure with digital tools, helping utilities and industrial users measure, monitor, and conserve water resources. Over more than a century, it has shifted from mechanical meters to connected hardware, sensors, and software.
Founded in 1905 and based in Milwaukee, Wisconsin, Badger Meter makes and sells flow-measurement and water-management products. These include mechanical and ultrasonic water meters, valves, sensing instruments, and radio communication endpoints. It also offers water-quality monitoring, pressure and leak-detection sensors, plus software that converts meter data into useful insights.
The business model mixes hardware sales with growing recurring software and service revenue. Flagship offerings include the BlueEdge suite of smart-water solutions, the cloud-hosted BEACON platform, ORION Cellular endpoints, and ultrasonic metering. These help utilities update older systems, spot leaks, cut non-revenue water, and share usage data with customers. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Badger Meter reports one operating segment, yet revenue splits into two lines. Utility Water makes up about 89% of net sales and targets municipal utilities with metering, advanced metering infrastructure, and software. Flow Instrumentation accounts for roughly 11% and supplies meters and sensors to original equipment makers and industrial clients in areas such as water treatment, HVAC, and sustainability efforts.
Most revenue comes from the United States, with smaller shares from Europe, Canada, Asia, and elsewhere. The company operates in a consolidating market and stands out through its broad product range, long utility relationships, and expanding software offerings.
Investors track BMI for steady, long-term demand rather than short cycles. Many U.S. municipal water systems are aging, and only about 40% of connections have moved to automated metering infrastructure. This leaves room for upgrades and replacements. From what I see, the company has expanded into water-quality monitoring, pressure management, and data analytics, turning equipment cycles into ongoing software relationships that support higher-margin revenue. Its profile often shows solid free cash flow, a conservative balance sheet, and a track record of dividend growth.
Several factors deserve attention. Badger Meter depends heavily on municipal budgets and project timing, which can lead to quarterly swings. Supply-chain issues matter too, with reliance on single sources for items like brass castings and electronics. Material costs, tariffs, and cybersecurity concerns around connected devices add layers of complexity. Competition in smart metering remains strong, and shifts in technology preferences could affect its position.
When analyzing stocks like this, I sometimes turn to Tickeron’s AI-powered platforms to quickly scan for comparable ideas across industries and technical patterns. It helps surface additional context without replacing deeper fundamental work.
Badger Meter represents a classic industrial name that has adapted into a smart-water technology player. Its mix of core infrastructure products, rising software revenue, and exposure to trends like aging systems and resource conservation creates a clear market role. While project timing, supply issues, and competition pose challenges, the underlying demand drivers and financial discipline keep it relevant for those following the water-technology space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 10-day moving average for BMI crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on BMI as a result. In 55 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 59%.
BMI moved above its 50-day moving average on October 21, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMI advanced for three days, in 184 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 110 of 211 cases where BMI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.
The 10-day RSI Indicator for BMI moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 15 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 50%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 40 of 63 cases where BMI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 63%.
The Moving Average Convergence Divergence Histogram (MACD) for BMI turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 23 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
BMI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. BMI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 49 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron Valuation Rating of 82 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.714) is normal, around the industry mean (1.448). P/E Ratio (36.786) is within average values for comparable stocks, (5.350). Projected Growth (PEG Ratio) (2.931) is also within normal values, averaging (5.470). Dividend Yield (0.011) settles around the average of (0.012) among similar stocks. P/S Ratio (4.255) is also within normal values, averaging (32.028).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a maker of flow measurement and control products
Industry ElectronicEquipmentInstruments